openPR Logo
Press release

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market worth XX billion/million by 2031 | Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan)

08-02-2022 01:27 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Global Insight Services

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market report from Global Insight Services is the single authoritative source of intelligence on Endoscopic Retrograde Cholangiopancreatography (ERCP) Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Endoscopic Retrograde Cholangiopancreatography (ERCP) Market here: https://www.globalinsightservices.com/reports/endoscopic-retrograde-cholangiopancreatography-ercp-market/

The global endoscopic retrograde cholangiopancreatography was valued at USD 1.5 billion in 2021 and it is anticipated to grow up to USD 2.9 billion by 2031, at a CAGR of 6.5% during the forecast period.

In order to diagnose and treat disorders of the bile and pancreatic ducts, endoscopic retrograde cholangiopancreatography (ERCP) combines endoscopy with x-ray technology. The use of precut sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) may increase the likelihood that a cannulation will be successful, but it is associated with an increased risk of post-ERCP pancreatitis.

Market Trends and Drivers:

The incidence of cancer is rising globally today. Cancer was the second-leading cause of death worldwide in 2018, accounting for 9.6 million fatalities, according to the WHO. The American Cancer Society predicts that in 2022, there will be roughly 41,260 new instances of liver cancer and intrahepatic bile duct cancer detected in the US. Since 1980, the incidence of liver cancer has more than tripled, while the fatality rate has more than doubled. About 60,430 new cases of the pancreatic disease were identified in the US in 2021.

Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS10278/

Market Segments:

By Product
Endoscopes
Endotherapy Devices
Visualization Systems

By Procedure
Biliary Sphincterotomy
Biliary Stenting

Major Players in the global endoscopic cholangiopancreatography Market:

The key players studied in the market are Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), B. Braun Melsungen AG (Germany), Hobbs Medical, Inc. (US)

Request For Customization - https://www.globalinsightservices.com/request-customization/GIS10278/

With Global Insight Services, you receive:

- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
& transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endoscopic Retrograde Cholangiopancreatography (ERCP) Market worth XX billion/million by 2031 | Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan) here

News-ID: 2695920 • Views:

More Releases from Global Insight Services

Liver Disease Treatment Market: Expansion Fueled by Increasing Incidence of NAFLD, NASH, and Alcohol-Related Liver Disease | Overall Study Report
Liver Disease Treatment Market: Expansion Fueled by Increasing Incidence of NAFL …
The Liver Disease Treatment Market continues to expand rapidly as global awareness, early diagnosis, and advanced therapeutic approaches reshape patient care. With the market valued at $26.6 billion in 2024 and projected to reach $44.8 billion by 2034 at a steady 5.4% CAGR, demand for effective and accessible therapies is on the rise. The Liver Disease Treatment Market covers pharmaceuticals, biologics, vaccines, diagnostics, and liver transplant services designed to manage
Healthcare Supply Chain BPO Market: Expansion Fueled by Increasing Outsourcing of Procurement, Logistics, and Inventory Management | Overall Study Report
Healthcare Supply Chain BPO Market: Expansion Fueled by Increasing Outsourcing o …
The Healthcare Supply Chain BPO Market is rapidly evolving as healthcare providers worldwide seek smarter, leaner, and more resilient operations. With growing pressure to reduce costs, boost efficiency, and maintain uninterrupted patient care, outsourcing supply chain tasks has become a strategic necessity. The global Healthcare Supply Chain BPO Market is projected to grow from $3.05 billion in 2024 to $4.83 billion by 2034, reflecting a CAGR of 4.7%. This expansion
Robotics Crawler Camera System Market Rise by 2034 | Key Players: Inuktun Services, Deep Trekker, Envirosight
Robotics Crawler Camera System Market Rise by 2034 | Key Players: Inuktun Servic …
Market Overview Robotics Crawler Camera System Market is witnessing a major transformation as industries shift toward advanced inspection technologies that improve safety, accuracy, and operational efficiency. These robotic crawlers, equipped with high-resolution cameras and strong maneuverability, enable real-time inspection across pipelines, sewers, industrial tanks, and hazardous environments where manual inspections pose risks. As automation becomes central to industrial maintenance, the Robotics Crawler Camera System Market continues to gain momentum, supported by
Pet DNA Testing Market Growth to 2034 | Key Players: Wisdom Panel, Embark Veterinary, DNA My Dog
Pet DNA Testing Market Growth to 2034 | Key Players: Wisdom Panel, Embark Veteri …
Market Overview Pet DNA Testing Market is rapidly transforming the way pet owners understand the health, ancestry, and traits of their companion animals. As pets increasingly become family members, owners are demanding deeper insights into their pets' genetic makeup. The Pet DNA Testing Market offers services such as breed identification, disease risk assessments, trait analysis, and ancestry mapping. With advancements in genomics and the expansion of direct-to-consumer testing kits, the Pet

All 5 Releases


More Releases for ERCP

North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
Introduction Biliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions. Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging
EU5 ERCP and PTC Devices Market to Reach USD 1.5 Billion by 2034
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) are essential diagnostic and therapeutic procedures used to treat conditions affecting the biliary and pancreatic ducts, such as gallstones, tumors, strictures, and obstructions. ERCP is a non-surgical procedure that combines endoscopy and fluoroscopy to evaluate the pancreatic and bile ducts, while PTC is used in cases where ERCP is not feasible, allowing direct visualization of the bile ducts via a needle
ERCP Device Market Size And Global Industry Forecast 2034
"The Endoscopic Retrograde Cholangiopancreatography (ERCP) device market is currently valued at approximately $1.2 billion in 2024. The market is projected to grow significantly, reaching an estimated $2.4 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034." Exactitude Consultancy., Ltd. released a research report titled "ERCP Device Market". This report covers the global ERCP Device market sales, sales volume, price,
Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by …
North America accounted for the largest share of the ERCP market. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this. According to the new market research report "Endoscopic Retrograde Cholangiopancreatography/ERCP Market [https://www.marketsandmarkets.com/Market-Reports/endoscopic-retrograde-cholangiopancreatography-ercp-market-170242954.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket] by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy),
ERCP Catheter Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growt …
ERCP Catheter Market The global ERCP Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for ERCP Catheter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030. Asia-Pacific market for ERCP Catheter is
Asia-Pacific ERCP Devices Market: Navigating Growth and Innovation
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a